Search by Drug Name or NDC

    NDC 68788-7269-09 Liothyronine Sodium 5 ug/1 Details

    Liothyronine Sodium 5 ug/1

    Liothyronine Sodium is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Preferred Pharmaceuticals Inc.. The primary component is LIOTHYRONINE SODIUM.

    Product Information

    NDC 68788-7269
    Product ID 68788-7269_db7483ea-0afc-4849-be24-3fe2b0314b1d
    Associated GPIs 28100020100305
    GCN Sequence Number n/a
    GCN Sequence Number Description n/a
    HIC3 n/a
    HIC3 Description n/a
    GCN n/a
    HICL Sequence Number n/a
    HICL Sequence Number Description n/a
    Brand/Generic n/a
    Proprietary Name Liothyronine Sodium
    Proprietary Name Suffix n/a
    Non-Proprietary Name Liothyronine Sodium
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET
    Route ORAL
    Active Ingredient Strength 5
    Active Ingredient Units ug/1
    Substance Name LIOTHYRONINE SODIUM
    Labeler Name Preferred Pharmaceuticals Inc.
    Pharmaceutical Class Triiodothyronine [CS], l-Triiodothyronine [EPC]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA200295
    Listing Certified Through 2024-12-31

    Package

    NDC 68788-7269-09 (68788726909)

    NDC Package Code 68788-7269-9
    Billing NDC 68788726909
    Package 90 TABLET in 1 BOTTLE (68788-7269-9)
    Marketing Start Date 2019-01-11
    NDC Exclude Flag N
    Pricing Information N/A